EPH82 Real-World Outcomes in Patients with Resected Non-Small Cell Lung Cancer (NSCLC) Receiving (NEO)Adjuvant Treatment in Germany: An I-O Optimise Analysis
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1124
https://www.valueinhealthjournal.com/article/S1098-3015(23)04254-7/fulltext
Title :
EPH82 Real-World Outcomes in Patients with Resected Non-Small Cell Lung Cancer (NSCLC) Receiving (NEO)Adjuvant Treatment in Germany: An I-O Optimise Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04254-7&doi=10.1016/j.jval.2023.09.1124
First page :
Section Title :
Open access? :
No
Section Order :
10606